• Catassi C, Bai JC, Bonez B, Bouma G, Calabró A, Carroccio A, et al. Non-celiac gluten sensitivity: the new frontier of gluten related disorders. Review. Nutrients. 2013;5:3839-53

• Biesiekirski JR, Peters SL, Newnham ED, Rosella O, Muir JG, Gibson PR. No effects of gluten in patients with self-reported non-celiac gluten sensitivity following dietary reduction of lowfermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology. 2013;145:320-8.

• Tavakkoli A, Lewis SK, Tennyson CA, Lebwohl B, Green PH. Characteristics of patients who avoid wheat and/or gluten in the absence of celiac disease. Dig Dis Sci. 2014;59(6):1255-61.

• Catassi C. Natural history of celiac disease autoinmunity in a USA cohort followed since 1974. Ann Med. 2010;42:530-8. 2.

• Verdu EF, Amstrong D, Murral JA. Between celiac disease and irritable bowel syndrome: the «no man’s land» of gluten sensivity. Am J Gastroenterol. 2009;104:1587-1594. 8.

• Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity and cancer. Physiol Rev. 2011;91:151-75. 30.

• Maiuri L, Ciacci C, Ricciardelli I, Vacca L, Raia V, Auricchio S, et al. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet. 2003; 362:30-7.

• Fasano A, Not T, Wang W, Uzzau S, Berti I, Tommasini A, et al. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet. 2000;355:1518-9.

• Chirdo FG, Garrote JA, Arranz E. Enfermedad celíaca. Nuevas perspectivas terapéuticas basadas en un mejor conocimiento de su patogenia molecular. Acta Gastroenterol Latinoam. 2005; 35: 183-9.

• Maiuri L, Ciacci C, Ricciardelli I, et al. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet. 2003; 362: 30-7.

• Maiuri L, Ciacci C, Auricchio S, et al. Interleukin-15 mediates epithelial changes in celiac disease. Gastroenterology. 2000; 119: 996-1006.